Summary:
IL-4, IL-10, interferon (IFN)-␥, TNF-␣, macrophage inflammatory protein (MIP)-1␣ were differentially expressed in acute and chronic GVHD in spleen cells. 6 We have investigated cytokine mRNA expression in the peripheral blood mononuclear cells of 20 patients who There was a dramatic increase in IL-2 mRNA in spleen cells during the early stage of progression of GVHD. 7 In received allogeneic hematopoietic stem cell transplants to assess the cytokine network after transplantation. ILcontrast, it was reported that marked increases of IL-1 mRNA in skin and spleen cells were observed, whereas 4 mRNA expression decreased in five of five (100%) patients with у у уgrade III (severe) acute GVHD and IL-2 and TNF-␣ mRNA expression slightly increased in GVHD mice.
8 increased in 10 of 22 (45%) patients without severe GVHD. In contrast, IL-12 mRNA expression increased We have investigated the cytokine network after allogeneic BMT using semiquantitative reverse transcriptase in two of two (100%) patients with severe GVHD, but increased in only six of 18 (33%) patients without severe polymerase chain reaction (RT-PCR). [9] [10] [11] In these studies, we have shown that inflammatory cytokine, such as IL-1␤, GVHD. Furthermore, IL-10 and/or IL-13 mRNA expression increased in 19 of 22 (86%) patients without IL-6, and TNF-␣, mRNA expression increased during the development of acute GVHD and that the degree of mRNA severe GVHD, but increased in only one of three (33%) patients with severe GVHD. In patients with allogeneic expression correlated well with the severity of GVHD. During limited chronic GVHD, IL-1␤ mRNA expression PBSCT who had severe acute GVHD, the cytokine mRNA expression in patients with allogeneic PBSCT, increased, but IL-6 and TNF-␣ mRNA expression did not increase or only slightly increased. In contrast, the who had no severe GVHD, showed a similar pattern to that in patients with allogeneic BMT. IL-4 mRNA expression of these cytokine mRNAs increased during extensive chronic GVHD. Furthermore, overexpression of expression increased in three of five (60%) patients and IL-10 and/or IL-13 mRNA expression increased in five these cytokine mRNAs could be detected before the clinical manifestations of GVHD developed. These studies indiof five (100%) patients. In contrast, IL-12 mRNA expression increased in only one of three (33%) patients.
cated an important role of inflammatory and immunostimulatory cytokines in PBMC in inducing GVHD after Serum IL-4 concentration in allogeneic PBSCT patients in the early engraftment phase was relatively high, while human BMT. Recently, it was reported that IL-4, IL-10 and IL-13 had serum IL-12 concentration was low. These findings suggest that severe GVHD may be related to the cytokine important inhibitory effects on Th1 cytokines and monokines. 12-14 IL-12 produced by monocytes, macrophages and imbalance between type 1 helper T (Th1) cells and type 2 helper T (Th2) cells.
antigen-producing cells (APC) has a potent role in inducing Th1 cytokines. Furthermore, the balance between IL-12 and Keywords: BMT; cytokine; GVHD; PBSCT IL-4 influences the early decision towards Th1 and Th2 cells in the immune response.
15-17
In this study, we have investigated Th2 cytokines (IL-4, Although GVHD is mainly caused by donor T lympho-IL-10 and IL-13) as well as IL-12, 18 in order to assess the cytes, cytokines play a central role in the regulation of cytokine network after allogeneic stem cell transplantation. immune responses and one manifestation of GVHD is the dysregulation of cytokines. [1] [2] [3] [4] Concerning cytokine mRNA expression in experimental murine bone marrow transplanPatients and methods tation, it has been reported that IL-1␣ and tumor necrosis factor (TNF)-␣ mRNA expression increased in the skin of Patients mice with GVHD. 5 amplified with each primer pair as a negative control but there was no specific amplified product (data not shown). plus total body irradiation (12 Gy in six fractions) for ALL. Allogeneic BMT patients were given cyclosporin A Also, ␤-actin gene expression was examined by the RT-PCR as an internal standard. (3 mg/kg) and methotrexate (15 mg/m 2 for 1 day and 10 mg/m 2 for 3 days) as prophylaxis for GVHD. In order to confirm semiquantitativity of this method, 5 g of total RNA from peripheral blood mononuclear cells Case 16 with ALL (L3) received allogeneic PBSCT for the treatment of incomplete recovery of platelets 95 days (PBMC) was reverse-transcribed in final 200 ml solution and 0.5, 1, 2, 5 or 10 ml of the resulting cDNA were ampliafter first allogeneic BMT. Two patients with ALL (L2), one patient with CML in chronic phase and one patient fied for 25 or 30 cycles with IL-12 primer pairs and 35 or 40 cycles with IL-4, IL-10 and IL-13 primer pairs then with NHL were treated by allogeneic BMT with allogeneic PBSCT (cases 17, 18, 19 and 20). Related donors who had subjected to electrophoresis on 2% agarose gel. In this study, when cytokine mRNA expression could be given informed consent were given 125 g of recombinant human granulocyte colony-stimulating factor (rhG-CSF, detected after amplification of 25, 30 or 35 cycles for IL-12 and 35, 40 or 45 cycles for IL-4, IL-10 and IL-13, they Kirin Breweries or Chugai Pharmaceutical, Tokyo, Japan) subcutaneously for 5 days and peripheral stem cell collecwere defined as +++, ++, +, ± or −, according to increasing amounts of product detectable. tion (PBSCC) was performed on the 4th and 5th days and 8-10 l of whole blood were processed using a blood cell separator (CS-3000; Fenwall Laboratories, Deerfield, IL, but increased in 10 of 22 (45%) patients without severe GVHD (Table 2 ). In contrast, IL-12 mRNA expression increased in two of two patients (100%) with severe GVHD, but it increased in only six of 18 (33%) patients without severe GVHD. Furthermore, IL-10 and/or IL-13 mRNA expression increased in three of five (60%) patients and also IL-10 and/or IL-13 mRNA expression increased mRNA expression increased in 19 of 22 (86%) patients without severe GVHD, whereas it increased in only one of in all five patients (100%). In contrast, IL-12 mRNA expression increased in only one of three (33%) patients, three (33%) patients with severe GVHD. We have performed five allogeneic PBSCTs and none of these patients thus showing a similar pattern to allogeneic BMT without severe GVHD. developed severe GVHD. After allogeneic PBSCT, IL-4 
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GVHD compared to those without severe GVHD. Also, ILallogeneic PBSCT patients 10 and IL-13 mRNA expression were simultaneously suppressed in severe GVHD patients. On the other hand, ILWe obtained six serum samples from five allogeneic 12 mRNA expression was increased in patients with severe PBSCT patients. In all these samples, IL-12 was detected GVHD. Therefore, it is conceivable that severe GVHD at a very low level, whereas IL-4 was detected at a reladeveloped in allogeneic BMT patients when the balance tively high level ( Table 3 ). The IL-4/IL-12 ratio increased between Th2 cytokines and IL-12 was shifted to induce at engraftment period after PBSCT compared with the preTh1 cells. However, our previous study indicated that ILtransplantation period. Since IL-4 (Th2 cytokine) was pre-2 mRNA expression in PBMC did not increase during dominant in the engraftment period after allogeneic PBSC, GVHD. 10 Cyclosporin A which is usually used as an severe acute GVHD appeared not to develop in such immunosuppressant for allogeneic transplants can suppress patients.
T cell function but cannot always suppress macrophagemonocyte function. 14,21,22 IL-4, IL-IL-2 mRNA expression in PBMC. 10 and IL-13 are usually considered to be important cytoClinical application of allogeneic PBSCT is a major topic kines with inhibitory effects on Th1 cytokines and monoin the field of clinical blood stem cell transplantation. [30] [31] [32] [33] [34] kines. 14,23-26 In addition, Th2 cells prevent LPS-induced Therefore, we have investigated the expression of cytokine lethality during murine graft-versus-host reaction. 27 On the mRNA in PBMC early after allogeneic PBSCT. 35 This other hand, IL-12 produced by monocytes, macrophages study suggested that immunosuppressive cytokine mRNA and antigen-producing cells (APC) has a potent role in expression in PBMC from allogeneic PBSCT patients was inducing Th1 cytokines. Thus Th1 cytokines have an increased compared with PBMC from autologous PBSCT, important role in the afferent phase of GVHD and Th1 autologous BMT patients and allogeneic BMT patients with response is critical for GVHD. The balance between IL-12 severe GVHD. In the present study, we have examined and IL-4 influences the early decision towards Th1 and Th2 serum IL-4 and IL-12 concentrations in allogeneic PBSCT cells in the immune response.
16,17 Therefore, IL-4 and ILpatients in the early engraftment phase in addition to cyto-12 in PBMC in patients receiving allogeneic BMT may kine mRNA expression. This assay showed low concenhave an important role in developing transplantation-related trations of IL-12 and relatively high concentrations of ILcomplications such as GVHD.
4 during that phase. The cytokine network might be shifted In this study, we have demonstrated that IL-4 gene expression in PBMC was suppressed in patients with severe to enhance immunosuppression in our allogeneic PBSCT In conclusion, the cytokine network, especially the bal- 
